Skip to main content

Clinical and Translational Oncology

Ausgabe 8/2024

Inhalt (24 Artikel)

Zebrafish live imaging: a strong weapon in anticancer drug discovery and development

  • REVIEW ARTICLE

Tiancheng Zhan, Wanqian Song, Guo Jing, Yongkang Yuan, Ning Kang, Qiang Zhang

Fertility preservation in hematological cancer patients

  • REVIEW ARTICLE

Dan Li, Yi-jun Zhao, Qian Wang, Man-wei Chu, Juan-ke Xie, Cui-lian Zhang

Genomic ancestry and cancer among Latin Americans

  • Open Access
  • SPECIAL ARTICLE

Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales, Claudio Martín, Sandra Franco, Luis Raez, Christian Rolfo, Natalia Sánchez, Andrés Felipe Cardona

Partial-accelerated irradiation with stereotactic radiotherapy at a dose of 30 Gy in 5 fractions in early breast cancer

  • RESEARCH ARTICLE

Javier Albendea Roch, Javier T. Anchuelo Latorre, M. Piedad Galdós Barroso, P. Navarrete Solano, Ana Laura Rivero Pérez, Frandeina Pinto Guevara, Mara García Lamela, Javier Olloqui Urroz, M. Díaz de Tuesta, Jesús Mazaira, Pedro Muñoz, Pedro J. Prada Gómez

Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study

  • RESEARCH ARTICLE

Serhat Sekmek, Irfan Karahan, Gokhan Ucar, Furkan Ceylan, Dogan Bayram, Ismet Seven, Hatice Bölek, Yüksel Ürün, Kadriye Bir Yücel, Ozan Yazici, Ahmet Kadioglu, Cengiz Karacin, Kubra Canaslan, Elif Atag, Serhat Demirer, Gokmen Umut Erdem, Yakup Ergun, Mehmetcan Atak, Baris Koksal, Merve Meryem Kiran, Duriye Ozer Turkay, Burak Civelek, Bulent Yalcin, Dogan Uncu

Identification of a gene expression signature associated with brain metastasis in colorectal cancer

  • Open Access
  • RESEARCH ARTICLE

Marlies Michl, Francesco Taverna, Christine Woischke, Pan Li, Frederick Klauschen, Thomas Kirchner, Volker Heinemann, Michael von Bergwelt-Baildon, Arndt Stahler, Tobias Marcus Herold, Vindi Jurinovic, Jutta Engel, Jörg Kumbrink, Jens Neumann

Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

  • Open Access
  • RESEARCH ARTICLE

Álvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso, Bartomeu Massuti, Raúl Márquez, Lourdes Calvo, Pedro Sánchez-Rovira, Antonio Antón, José Ignacio Chacón, Eva Ciruelos, Jose Juan Ponce, Ana Santaballa, Manuel Valladares-Ayerbes, María Rosario Dueñas, Vicente Alonso, Jorge Aparicio, Sara Encinas, Luis Robles, María José Escudero, Rosalía Caballero, Susana Bezares, Juan de la Haba-Rodriguez

Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval

  • RESEARCH ARTICLE

Olajumoke Adenike Olateju, Zhen Zeng, Marjan Zakeri, Sujit S. Sansgiry

The diagnostic and prognostic value of exosomal microRNAs in lung cancer: a systematic review

  • RESEARCH ARTICLE

Bingbing Yang, Xiaoqi Xin, Xiaoqing Cao, Lubanga Nasifu, Zhenlin Nie, Bangshun He

Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer

  • Open Access
  • RESEARCH ARTICLE

Xiaoming Wang, Dayu Chen, Yuyan Ma, Dongping Mo, Feng Yan

Computed tomography-based radiomics nomogram for predicting therapeutic response to neoadjuvant chemotherapy in locally advanced gastric cancer

  • RESEARCH ARTICLE

Wenjing Chen, Weiteng Zhang, Xietao Chen, Weisong Dong, Yiqi Cai, Jun Cheng, Jinji Jin

Contouring aid tools in radiotherapy. Smoothing: the false friend

  • RESEARCH ARTICLE

Jordi Marruecos Querol, Diego Jurado-Bruggeman, Anna Lopez-Vidal, Ricard Mesía Nin, Jordi Rubió-Casadevall, Maria Buxó, Aranzazu Eraso Urien

Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy

  • Open Access
  • RESEARCH ARTICLE

Yuanliang Zhou, Jingchao Li, Yankang Li, Guangchuan Deng, Qi Wang, Hongyue Qin, Jianbin Li, Zhenxiang Li

Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer

  • Open Access
  • RESEARCH ARTICLE

Wei Wang, Yisen Huang, Jianqiao Kong, Lin Lu, Qianxiu Liao, Jingtao Zhu, Tinghao Wang, Linghua Yan, Min Dai, Zhan Chen, Jun You

Circulating serum exosomes i-tRF-AspGTC and tRF-1-SerCGA as diagnostic indicators for non-small cell lung cancer

  • RESEARCH ARTICLE

Jiefei Peng, Yue Zhang, Guangfei Zhou, Luolin Shao, Lin Li, Zhijun Zhang

Clinical risk prediction model and external validation of positive surgical margin in laparoscopic radical prostatectomy based on MRI lesion location

  • RESEARCH ARTICLE

Xin Chen, Chaozhong Wang, Yongchang Chen, Chengbo Qian, Renpeng Huang, Jie Bao, Yuxin Lin, Jianquan Hou, Yuhua Huang, Xuedong Wei

Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers

  • RESEARCH ARTICLE

Tianqi An, Qiu Hui, Hong Zong, Linhua Liu, Xinguang Cao, Rui Li, Shuang Hu, Yiyi Liu, Jia Li, Ruihua Zhao

Assessment of TUFT1 and Rac1-GTP levels in triple-negative breast cancer patients: clinical and pathological correlations

  • RESEARCH ARTICLE

Su-fang Shi, Rui-xi Cai, Yan-fei Ren, Yong Li, Shuo Li, Tian-lu Yin, Dong-xiao Jia, Yong-jun Li

Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data

  • RESEARCH ARTICLE

Yang Liu, Fenglong Bie, Guangyu Bai, Qilin Huai, Yuan Li, Xiaowei Chen, Bolun Zhou, Shugeng Gao

The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis

  • RESEARCH ARTICLE

Miaomiao Wang, Liang Cao, Yinzhong Wang, Hongliang Huang, Xiaoxue Tian, Junqiang Lei

Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer

  • RESEARCH ARTICLE

Guangming Ren, Gaozan Zheng, Kunli Du, Zhangfeng Dang, Hanjun Dan, Xinyu Dou, Lili Duan, Zhenyu Xie, Liaoran Niu, Ye Tian, Jianyong Zheng, Fan Feng

Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey

  • Open Access
  • BRIEF RESEARCH ARTICLE

Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martín

Comparative study of weekly and three-weekly neoadjuvant carboplatin in triple-negative breast cancer: retrospective analysis in real-world settings

  • BRIEF RESEARCH ARTICLE

Ana Isabel Martin-Quesada, Elisenda Llabres-Valentí, Cristina María Montesdeoca-Godoy, Carla Martín-Abreu, Cristina Alemán-Sánchez, Natalia Rodríguez-Pérez, Alicia Herrero-Márquez, Josefina Cruz-Jurado, María Hernández-Sosa, Melody Marrero-García, Cristina Victoria DelPino-Hernández, Samuel José Hernández-Sarmiento, Alejandra Rodríguez-Capote, Lina Pérez-Méndez, Isaac Núñez-Hernández

Neu im Fachgebiet Onkologie

Kopf-Hals-Tumoren: Die Immuntherapie ist kein Selbstläufer

Ergebnisse einer weiteren Studie legen nahe: Mit einer adjuvanten Immuncheckpointhemmung ist lokal fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereichs nur schwer beizukommen. Einige Fachleute geben die Hoffnung jedoch nicht auf und diskutieren mögliche Gründe für die negativen Ergebnisse.

Dänische Zwillingsstudie deutet auf erhöhtes Krebsrisiko bei Tätowierten hin

Haben Tattoo-Träger und -Trägerinnen ein erhöhtes Risiko, an Hautkrebs oder einem Lymphom zu erkranken? Die Ergebnisse einer Zwillingsstudie aus Dänemark scheinen dafür zu sprechen. Die Forschungsgruppe rät vorerst zur Zurückhaltung beim Tätowieren.

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.